BU-NOT-SET

CONTACT US
Successful drug development
  • Drug product
Eyes
Insight
How CDMOs can help reduce the risk of counterfeit medicines entering the supply chain
  • Manufacturing
Eyes
Insight
Tackling complexity in scale-up
  • Drug product
Lab equipment
Insight
Navigating COVID-19 – the role of CDMOs
  • Industry trends
Eyes
Insight
Best pharmaceutical dosage forms
  • Drug product
Production line
Insight
Taking an innovative approach to analytical chemistry
  • Analytical chemistry
Eyes
Insight
Recipharm and Oncopeptides collaborate in the development of Melflufen for the treatment of multiple myeloma
  • Analytical chemistry
Eyes
Insight
Excipients for orally disintegrating products
  • Drug product
Eyes
Insight
Recipharm increases API and raw material stocks to ensure supply amid higher antibiotics demand
  • Drug substance
Eyes
Insight
Insight
  • Manufacturing
Why outsourcing is key to bringing flexibility and capacity to the manufacture of oral solid dosage forms
Insight
  • Industry trends
Can bigger be better?
Insight
  • Industry trends
What does 2017 have in store for the pharma industry?
Insight
  • Industry trends
Reflecting on 2017 | the factors shaping our industry
Insight
  • Manufacturing
Protecting against counterfeiting with serialisation
Insight
  • Industry trends
Manufacturing Chemist CDMO roundtable – part two
Insight
  • Industry trends
Manufacturing Chemist CDMO roundtable – part one
Insight
  • Industry trends
  • Manufacturing
Increased drive to outsource manufacturing in life science
Insight
  • Manufacturing
Serialisation: the final countdown